Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001064 · ClinicalTrials.gov registry record · NA
A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Terminated
- Registry status
- NA
- Development phase
NCT00001064: Clinical Trial NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00001064 is a NA study that was terminated before completion, run by National Institute of Allergy and Infectious Diseases (NIAID). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001064, a NA study, was terminated before completion, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- TERMINATED
- Registry status
- NA
- Development phase
Study Summary
To define the safety and efficacy of sibling-supplied, HIV antigen-pulsed dendritic cells in increasing the immune response in HIV-infected patients. Dendritic cells are a type of white blood cell used by the body to fight infection. They are instrumental in presenting antigens (such as HIV antigens) to the body's immune system. Since dendritic cells are not functioning maximally in HIV-infected patients, infusion of dendritic cells from an HIV-negative sibling may enable the affected sibling's immune system to recognize foreign particles more readily and increase immune response against the virus.
Interventions
- DRUG Allogenic Dendritic Cells
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2005-06 |
| Phase | NA |
Why NCT00001064 stopped before completion
NCT00001064 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Allogenic Dendritic Cells is the first listed.
NCT00001064 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001064 about?
NCT00001064 is a clinical study titled "A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3". To define the safety and efficacy of sibling-supplied, HIV antigen-pulsed dendritic cells in increasing the immune response in HIV-infected patients. Dendritic cells are a type of white blood cell used by the body to fight infection. They are instrumental in presenting antigens (such as HIV antigen...
What is the current status of trial NCT00001064?
This trial is currently terminated. It is a NA study. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00001064?
The interventions under investigation include: Allogenic Dendritic Cells (DRUG).
Who is sponsoring clinical trial NCT00001064?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.